NCT06268951View on ClinicalTrials.gov

Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis

Enrolling by invitationOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 9, 2024

Primary Completion Date

February 28, 2027

Study Completion Date

December 31, 2027

Conditions
Endometriosis
Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06268951 - Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis | Biotech Hunter | Biotech Hunter